---
figid: PMC11994599__fphar-16-1554696-g009
figtitle: 'Salvia miltiorrhiza Bunge root in the treatment of myocardial fibrosis:
  research progress and challenges'
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC11994599
filename: fphar-16-1554696-g009.jpg
figlink: /pmc/articles/PMC11994599/figure/F9/
number: F9
caption: Mechanism of Salvia miltiorrhiza Bunge in the treatment of MF (① SM inhibitsMFby
  downregulating TGF-β1, Smad2/3, and their phosphorylation levels; ② SM inhibits
  MF by downregulating the phosphorylation levels of PI3K, Akt, and mTOR proteins;
  ③ SM inhibits MF by downregulating the expression of TLR4 and the activation of
  downstream TAK1 and NF-κB; ④ SM inhibits apoptosis and MF by upregulating the expression
  of Bax, Caspase-3, Caspase-9, and cytochrome C, and downregulating Bcl-2 protein;
  ⑤ SM regulates the TIMP-1/MMPs pathway to inhibit MF by downregulating the expression
  of MMP2 and MMP9, and upregulating TIMP-1 expression; ⑥ SM regulates the Nrf2/HO-1
  signaling pathway to inhibit MF by upregulating the expression of antioxidant proteins
  such as Nrf2 and HO-1)
papertitle: 'Salvia miltiorrhiza Bunge root in the treatment of myocardial fibrosis:
  research progress and challenges'
reftext: Qianrong Li, et al. Front Pharmacol. 2025;16(NA).
year: '2025'
doi: 10.3389/fphar.2025.1554696
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media SA
keywords: natural medicine Salvia miltiorrhiza Bunge | MF | advancements in research
  | metabolites | pharmacological mechanism
automl_pathway: 0.9312205
figid_alias: PMC11994599__F9
figtype: Figure
redirect_from: /figures/PMC11994599__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11994599__fphar-16-1554696-g009.html
  '@type': Dataset
  description: Mechanism of Salvia miltiorrhiza Bunge in the treatment of MF (① SM
    inhibitsMFby downregulating TGF-β1, Smad2/3, and their phosphorylation levels;
    ② SM inhibits MF by downregulating the phosphorylation levels of PI3K, Akt, and
    mTOR proteins; ③ SM inhibits MF by downregulating the expression of TLR4 and the
    activation of downstream TAK1 and NF-κB; ④ SM inhibits apoptosis and MF by upregulating
    the expression of Bax, Caspase-3, Caspase-9, and cytochrome C, and downregulating
    Bcl-2 protein; ⑤ SM regulates the TIMP-1/MMPs pathway to inhibit MF by downregulating
    the expression of MMP2 and MMP9, and upregulating TIMP-1 expression; ⑥ SM regulates
    the Nrf2/HO-1 signaling pathway to inhibit MF by upregulating the expression of
    antioxidant proteins such as Nrf2 and HO-1)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - tgfb1a
  - nfe2l2a
  - myd88
  - ticam1
  - baxa
  - mmp2
  - chmp2a
  - mmp9
  - nox4
  - met
  - th2
  - TLR4
  - TGFB1
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - NFKB1
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - TIMP1
  - HMOX1
  - GABPA
  - NFE2L2
  - MYD88
  - TRIM69
  - TICAM1
  - BAX
  - TGFB2
  - TGFB3
  - ACTA1
  - BCL2
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - CYBB
  - NOX4
  - NELFCD
  - SOD1
  - SOD2
  - SOD3
  - Nucleus
  - Collagen
  - MDA
---
